Personalis, Inc. Interest Expense
Personalis, Inc. (PSNL) reported Interest Expense of $37.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-04
- Personalis, Inc. interest expense for the quarter ending 2026-06-30 was $37.00K, a 22.92% decline year-over-year.
- Personalis, Inc. interest expense for the quarter ending 2026-03-31 was $47.00K, a 67.86% increase year-over-year.
- Personalis, Inc. interest expense for the quarter ending 2025-12-31 was $65.00K.
- Personalis, Inc. interest expense for the quarter ending 2025-09-30 was $64.00K, a 814.29% increase year-over-year.
- Personalis, Inc. interest expense for fiscal 2025 was $205.00K, a 754.17% increase from fiscal 2024.
- Personalis, Inc. interest expense for fiscal 2024 was $24.00K, a 78.18% decline from fiscal 2023.
- Personalis, Inc. interest expense for fiscal 2023 was $110.00K, a 45.27% decline from fiscal 2022.
- Personalis, Inc. interest expense for fiscal 2022 was $201.00K, a 9.24% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $37.00K 10-Q · filed 2026-08-04 | $84.00K 10-Q · filed 2026-08-04 | $149.00K derived: sum of 3 quarters · filed 2026-08-04 | $213.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $47.00K 10-Q · filed 2026-05-07 | $112.00K derived: sum of 2 quarters · filed 2026-05-07 | $176.00K derived: sum of 3 quarters · filed 2026-05-07 | $224.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $129.00K derived: sum of 2 quarters · filed 2026-02-26 | $177.00K derived: sum of 3 quarters · filed 2026-08-04 | $205.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $64.00K 10-Q · filed 2025-11-04 | $112.00K derived: sum of 2 quarters · filed 2026-08-04 | $140.00K 10-Q · filed 2025-11-04 | $139.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $48.00K 10-Q · filed 2026-08-04 | $76.00K 10-Q · filed 2026-08-04 | $75.00K derived: sum of 3 quarters · filed 2026-08-04 | $82.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $28.00K 10-Q · filed 2026-05-07 | $27.00K derived: sum of 2 quarters · filed 2026-05-07 | $34.00K derived: sum of 3 quarters · filed 2026-05-07 | $43.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.00K derived: sum of 2 quarters · filed 2026-02-26 | $15.00K derived: sum of 3 quarters · filed 2026-02-26 | $24.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.00K 10-Q · filed 2025-11-04 | $16.00K derived: sum of 2 quarters · filed 2025-11-04 | $25.00K 10-Q · filed 2025-11-04 | $34.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $9.00K 10-Q · filed 2025-08-05 | $18.00K 10-Q · filed 2025-08-05 | $27.00K derived: sum of 3 quarters · filed 2025-08-05 | $42.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-06 | $18.00K derived: sum of 2 quarters · filed 2025-05-06 | $33.00K derived: sum of 3 quarters · filed 2025-05-06 | $72.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $24.00K derived: sum of 2 quarters · filed 2025-02-27 | $63.00K derived: sum of 3 quarters · filed 2025-02-27 | $110.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-06 | $54.00K derived: sum of 2 quarters · filed 2024-11-06 | $101.00K 10-Q · filed 2024-11-06 | $148.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $39.00K 10-Q · filed 2024-08-07 | $86.00K 10-Q · filed 2024-08-07 | $133.00K derived: sum of 3 quarters · filed 2024-08-07 | $178.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $47.00K 10-Q · filed 2024-05-08 | $94.00K derived: sum of 2 quarters · filed 2024-05-08 | $139.00K derived: sum of 3 quarters · filed 2024-05-08 | $189.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $92.00K derived: sum of 2 quarters · filed 2024-02-28 | $142.00K derived: sum of 3 quarters · filed 2024-02-28 | $201.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $45.00K 10-Q · filed 2023-11-07 | $95.00K derived: sum of 2 quarters · filed 2023-11-07 | $154.00K 10-Q · filed 2023-11-07 | $213.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $50.00K 10-Q · filed 2023-08-08 | $109.00K 10-Q · filed 2023-08-08 | $168.00K derived: sum of 3 quarters · filed 2024-02-28 | $228.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $59.00K 10-Q · filed 2023-05-03 | $118.00K derived: sum of 2 quarters · filed 2024-02-28 | $178.00K derived: sum of 3 quarters · filed 2024-02-28 | $243.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $119.00K derived: sum of 2 quarters · filed 2024-02-28 | $184.00K derived: sum of 3 quarters · filed 2024-02-28 | $184.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $60.00K 10-Q · filed 2022-11-02 | $125.00K derived: sum of 2 quarters · filed 2022-11-02 | $125.00K 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $65.00K 10-Q · filed 2022-08-03 | $65.00K 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $2.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $2.00K 10-Q · filed 2021-11-04 | $2.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.00K 10-Q · filed 2021-08-04 | $2.00K derived: sum of 3 quarters · filed 2022-02-24 | $206.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-05 | $2.00K derived: sum of 2 quarters · filed 2022-02-24 | $206.00K derived: sum of 3 quarters · filed 2022-02-24 | $951.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $204.00K derived: sum of 2 quarters · filed 2022-02-24 | $949.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.13M 10-K · filed 2022-02-24 |
| 2019-09-30 | $204.00K 10-Q · filed 2020-11-05 | $949.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.13M 10-Q · filed 2020-11-05 | $1.38M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $745.00K 10-Q · filed 2020-08-06 | $929.00K 10-Q · filed 2020-08-06 | $1.17M derived: sum of 3 quarters · filed 2021-02-25 | $1.63M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $184.00K 10-Q · filed 2020-05-07 | $428.00K derived: sum of 2 quarters · filed 2021-02-25 | $883.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.46M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $699.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.27M derived: sum of 3 quarters · filed 2021-02-25 | $1.89M 10-K · filed 2021-02-25 |
| 2018-09-30 | $455.00K 10-Q · filed 2019-11-13 | $1.03M derived: sum of 2 quarters · filed 2019-11-13 | $1.65M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $573.00K 10-Q · filed 2019-08-13 | $1.20M 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $1.30M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |